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Soil-transmitted helminths (STHs), including Ascaris, Trichuris 
and hookworms, cause neglected tropical diseases affecting >1 bil-
lion people worldwide1,2. Hookworms alone infect approximately 
700 million people, primarily in disadvantaged communities in tropical 
and subtropical regions, causing a disease burden of 1.5–22.1 million 
disability-adjusted life years3. N. americanus represents ~85% of 
all hookworm infections4 and causes necatoriasis, characterized 
clinically by anemia, malnutrition in pregnant women, and an 
impairment of cognitive and/or physical development in children5.
The life cycle of N. americanus commences with eggs being shed in 
the feces of infected people. Eggs embryonate in soil under favorable 
conditions, and then the first-stage larvae hatch, feed on environmen-
tal microbes and molt twice to become infective third-stage larvae 
(iL3). These larvae infect the human host by skin penetration, enter 
subcutaneous blood and lymph vessels, and travel via the circulation 
to the lungs. The iL3 break into the alveoli and migrate via the tra-
chea to the oropharynx, after which they are swallowed and travel to 
the small intestine, where they develop to become dioecious adults. 
The adult worms (~1 cm long) attach to the mucosa, where they feed 
on blood (up to 30 µl per day per worm), and can survive in the human 
host for up to a decade. The pre-patent period of N. americanus is 
4–8 weeks, and a female worm can produce up to 10,000 eggs per day.
New methods to control hookworm disease are urgently needed. 
Present therapy relies mainly on mass treatment with albendazole6, 
but repeated and excessive use of this agent has the potential to lead to 
treatment failures7 and drug resistance8. Recent indications of reduced 
cure rates in infected humans9 imply an urgent need for new interven-
tion strategies. Early attempts to use bioinformatic approaches for the 
discovery of immunogens were hampered by a lack of understanding 
of the molecular biology of N. americanus and other hookworms4 and 
by the absence of genome and proteome sequences. A recent study10 
has shown that comparative genomics facilitates the characterization 
and prioritization of anthelmintic targets, which results in a higher 
hit rate than conventional approaches.
In addition to a need for anti-hookworm vaccines in countries with 
high rates of hookworm infections, hookworms and other helminths 
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are being explored as treatments (probiotics) against immunological 
diseases in humans in many industrialized countries where hookworm 
infections are not endemic11. Recent studies12–14 indicate that hook-
worms suppress the production of pro-inflammatory molecules and 
promote anti-inflammatory and wound-healing properties, suggest-
ing a mechanism by which worms reside for long periods in humans 
and suppress autoimmune and allergic diseases. Indeed, hookworm 
recombinant proteins have been tested in clinical trials for non-
infectious diseases15.
We sequenced, assembled and characterized the N. americanus 
genome and compared it with those of other nematodes and the 
human host. Bioinformatic analyses of the protein-coding genes 
identified salient molecular groups, some of which may represent 
new intervention targets. The production and screening of a hook-
worm protein microarray revealed previously undescribed features 
of the immune response to the parasite and enabled a postgenomic 
exploration of the genome sequence. In the postgenomic analysis, 
we identified molecules that have low similarity to proteins in other 
species but are recognized by all infected individuals and therefore 
have high diagnostic potential.
RESULTS
Genome features
The nuclear genome of N. americanus (244 megabases (Mb)) was 
assembled, with 11.4% (1,336) of the supercontigs (≥1 kb) comprising 
90% of the genome. The 244-Mb sequence was estimated to represent 
92% of the N. americanus genome (Table 1, Supplementary Figs. 1–3 
and Supplementary Note). The GC content was 40.2%, the amino acid 
composition was comparable to that of other species (including five 
nematodes, the host and two outgroups; Supplementary Table 1) and 
the repeat content was 23.5%. In total, 669 repeat families were pre-
dicted and annotated (Supplementary Table 2 and Supplementary 
Note). The protein-encoding genes predicted (n = 19,151) represent 
33.7% of the genome at an average density of 78.5 genes per Mb and 
a GC content of 45.8%.
Compared to those of Caenorhabditis elegans, N. americanus exons 
were shorter and the introns were longer (Fig. 1a), but the average 
intron length and count for genes orthologous between the two spe-
cies was not significantly different (P = 0.65 and 0.69, respectively; 
Fig. 1a,b and Supplementary Note). However, introns in C. elegans 
genes that were orthologous to N. americanus genes were significantly 
longer than introns in nonorthologous C. elegans genes (P < 1 × 10−15; 
Fig. 1c). This may indicate a diversity of function for these genes, as 
longer introns are thought to contain functional elements in addition 
to what might be regarded as ‘normal’ intron structure16. Furthermore, 
N. americanus iL3-overexpressed genes had longer introns than adult-
overexpressed genes (Fig. 1b), which may indicate a greater diversity of 
regulation for these gene sets16. Positional bias was observed for intron 
length, which was comparable to C. elegans position-specific intron 
lengths for orthologous genes (Fig. 1c and Supplementary Note).
Most genes (82.6%) were confirmed using RNA sequencing (RNA-
seq) data from the iL3 and adult stages of N. americanus (two bio-
logical replicates per stage), and 6.5% and 3.7% were overexpressed 
in these stages, respectively (Supplementary Figs. 4 and 5, and 
Supplementary Table 3). Alternative splicing was detected for 24.6% 
(4,712) of the genes, of which ~68.3% have orthologs in C. elegans. 
Among N. americanus genes with C. elegans orthologs, the alterna-
tively spliced genes were more likely than other genes to belong to 
orthologous groups for which more than half of the C. elegans genes 
were also alternatively spliced (P = 0.037, binomial distribution test). 
As expected, genes associated with alternative splicing had a higher 
number of exons than those without (P < 10−15 and 2 × 10−7 for 
N. americanus and C. elegans, respectively). A total of 3,223 
N. americanus genes were predicted to be trans-spliced, of which 818 
had conserved gene order and orientation with 373 C. elegans oper-
ons (Fig. 1d, Supplementary Figs. 6 and 7, Supplementary Table 4 
and Supplementary Note). The expression profiles of genes within 
operons were significantly more similar to one another than to those 
of random subsets of non-operon genes (P < 0.0001), supporting the 
idea that they are co-transcribed under similar regulatory control17.
The N. americanus predicted secretome (classical secretion, 1,590 
proteins; nonclassical secretion, 4,785 proteins) represented 33% of 
the deduced proteome. Functional annotation of predicted proteins 
on the basis of sequence comparisons identified 4,961 unique domains 
and 1,411 Gene Ontology terms for 57% and 44% of the N. americanus 
genes, respectively, and annotations were provided for 68% of the 
predicted N. americanus proteins (Supplementary Table 5).
Transcript expression in infective and parasitic stages
Hookworms spend a considerable amount of time as free-living 
larvae in the external environment before transitioning to parasitism. 
Differences in gene expression between these stages reflect this develop-
mental progression (Supplementary Table 3 and Supplementary 
Fig. 5). Of the 1,948 differentially expressed genes, 36% were signi-
ficantly overexpressed (according to EdgeR, q = 0.05) in iL3, and 
64% in adult. Compared to iL3-overexpressed genes, nearly twice as 
many of the adult-overexpressed genes were specific to N. americanus 
(58% compared to 32%, P < 10−15), suggesting that species-specific 
genes are more likely to be related to parasitism rather than to the 
nonparasitic iL3 stage18.
Among the iL3-overexpressed genes, eight molecular functions 
were over-represented (P < 0.01), including signal transduction, trans-
membrane receptor activity and anion transporter activity, reflecting 
the ability of iL3 to adapt to a complex environment and infect a 
suitable host (Fig. 2a, Supplementary Table 6 and Supplementary 
Note). This finding is supported by the enrichment of genes encod-
ing G protein–coupled receptor proteins among iL3-overexpressed 
genes (P = 5.1 × 10−8) but not among adult-overexpressed genes 
(P = 4.1 × 10−7) (Supplementary Fig. 8). Consistent with observations 
in other parasitic nematodes19, serine/threonine protein kinase activity 
table 1 summary of N. americanus genomic features
estimated genome size (Mb) 244
Assembly statistics
 Total number of supercontigs (≥1 kb) 11,713
 Total number of base pairs (bp) in supercontigs 244,009,025
 Number of N50 supercontigsa 283
 N50 supercontig length (bp)a 213,095
 Number of N90 supercontigsa 1,336
 N90 supercontig length (bp)a 29,214
 GC content of whole genome 40.20%
 Repetitive sequences 23.50%
Protein-coding loci
 Total number of protein-coding genes 19,151
 Avg. gene locus footprint (bp) 4,289
 Avg. number of exons per gene 6.4
 Avg. exon size (bp) 125
 Avg. intron size (bp) 642
 Avg. intergenic space (bp) 6,631
aN50 and N90 respectively denote 50% and 90% of all nucleotides in the assembly. 50%  
of the genome is in 283 supercontigs and in supercontigs with a minimum length of  
213 kb; 90% of the genome is in 1,336 supercontigs and in supercontigs with a minimum 
length of 29 kb.
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was also enriched among iL3-overexpressed genes (P = 0.008). The 
complexity of transcription regulatory activities is likely to be high in 
iL3, as evidenced by the enrichment of genes annotated with “sequence-
specific DNA binding transcription factor activity” (GO:0003700; 
P = 1.7 × 10−14) and genes with alternative splicing (P < 2 × 10−13), 
and by the fact that most (92.5%) of the differentially expressed tran-
scription factors were iL3 overexpressed (Supplementary Note). This 
iL3-stage enrichment of transcription factor–related activity might 
indicate that transcription factors are poised for rapid gene expression 
after host invasion (that is, gene expression is not active but is likely 
to be primed, as observed in arrested stages of C. elegans20).
In contrast, in the adult stage, we detected overexpression of 
transcripts for a broad spectrum of enzymes including proteases, 
hydrolases and catalases (Supplementary Table 6). This reflects 
the nutritional adaptation of adult worms to a high-protein diet of 
blood21 (Fig. 2, Supplementary Fig. 9 and Supplementary Note). 
Proteins with a signal peptide (SP) for secretion had transcripts that 
were enriched among adult-overexpressed genes (P < 10−15), whereas 
transmembrane domain–containing proteins (P = 1.2 × 10−8) had 
transcripts enriched among iL3-overexpressed genes. Proteases 
and protease inhibitors were enriched among SP-containing genes, 
and proteases contributed substantially to the predicted secretome 
(Supplementary Table 6 and Supplementary Note), with 55% of all 
proteases (325 of 592) predicted to be secreted. Proteases, particularly 
N. americanus–specific proteases with no orthologs in C. elegans, were 
overexpressed more often in adult than in iL3 (P < 10−15 for both 
comparisons; Fig. 2b,c, Supplementary Note and Supplementary 
Table 7). Serine-type endopeptidase inhibitor activity, required to 
protect the adult stage from the digestive and immunologically hostile 
environment in the host22, was adult enriched (P = 1.6 × 10−4). The 
d
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Figure 1 Organization of N. americanus gene features compared to C. elegans. (a) The average exon in N. americanus genes is significantly  
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adult enrichment of genes encoding structural constituents of the cuticle 
(P = 1.7 × 10−5) also relates to protecting the parasite from the host23.
Blood feeding in adult hookworms is facilitated by an anticoagula-
tion process and degradation of blood proteins by proteases. Known 
hookworm anticoagulants24 are dominated by single-domain serine 
protease inhibitors (SPIs). We annotated 87 SPIs in N. americanus, 
accounting for 8 of 17 protease inhibitor clans. Given that serine 
proteases in humans are involved in diverse physiological func-
tions, including blood coagulation and immunomodulation, the 
diversity of SPIs in N. americanus is probably crucial not only for 
anticoagulation during blood feeding but also for long-term survival 
in the host. Specifically, SPIs are likely to protect adult worms from 
enzymes in the small intestine, where serine proteases, including 
trypsin, chymotrypsin and elastase, are prominent25, thus mediat-
ing hookworm-associated growth delay22. SPIs were enriched among 
the adult-overexpressed genes (P = 3.9 × 10−8), but not among the 
iL3-overexpressed genes (P = 0.35). Most of the SPIs characterized 
in hookworms were Kunitz-type molecules (Supplementary Note), 
but our findings suggest that multiple types of SPIs are produced by 
adult N. americanus in the human host. A mass spectrometry–based 
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proteomics analysis was performed using whole adult N. americanus 
worms (Online Methods), and the proteins detected (Supplementary 
Table 7 and Supplementary Fig. 10) were also enriched for proteases 
(P = 4.9 × 10−7) and SPIs (P = 1.8 × 10−4), as well as proteins with 
SPs (P = 4.7 × 10−11) and proteins representing a wide range of 
Gene Ontology terms, many related to proteolysis (Supplementary 
Table 6 and Supplementary Note).
Pathogenesis and immunobiology of hookworm disease
N. americanus causes chronic disease and does not usually induce 
sterile immunity in the host. Adult hookworms are able to live 
in the host for several years because of their ability to modu-
late and evade host immune defenses13 with their excretory- 
secretory products, which sustain development and create a 
site of immune privilege26. By comparing the N. americanus 
genome with genomes from other nematodes, its host and distant 
species, we identified molecules that facilitate parasitism. Sixty 
percent of N. americanus genes had an ortholog in the other spe-
cies studied (Supplementary Table 8, Supplementary Fig. 11  
and Supplementary Note). Comparative analysis identified 
metalloendopeptidases as the most prominent N. americanus  
proteases (Fig. 2a); these proteases are probably associated with 
the cleavage of eotaxin and inhibition of eosinophil recruitment27, 
in addition to tissue penetration28 and hemoglobinolysis29. 
N. americanus is the only blood-feeding nematode included in the 
comparison, and the hierarchical structure for enriched molecular 
functions (Fig. 2a) revealed shared and unique patterns and sub-
sequent functional relationships.
SCP/Tpx-1/Ag5/PR-1/Sc7 (SCP/TAPS; InterPro IPR014044; 
Supplementary Table 5) is a protein family inferred to be involved 
in host-parasite interactions (Supplementary Note). There were 
137 SCP/TAPS proteins in N. americanus, representing a fourfold 
expansion of this protein family compared to other nematodes. 
More than half (69 of 137) of the N. americanus SCP/TAPS proteins 
were adult overexpressed (P < 10−15; Fig. 3a), and only 6 of the 
137 N. americanus SCP/TAPS proteins had orthologs in C. elegans 
(according to Markov clustering (MCL); see Online Methods). The 
presence of a limited repertoire of orthologs in C. elegans suggests 
that nematode SCP/TAPS proteins may have originated before 
parasitism. Primary sequence similarity classified SCP/TAPS pro-
teins into multiple groups (Fig. 3b,c and Supplementary Fig. 12), 
only some of which contained C. elegans members, suggesting 
independent expansion of SCP/TAPS proteins after parasite spe-
ciation. The large expansion of SCP/TAPS proteins in N. ameri-
canus suggests multiple, possibly distinct roles in host-parasite 
interactions. SCP/TAPS proteins have been studied extensively 
as hookworm drug or vaccine candidates30 and as therapeutics 
for human inflammatory diseases15 or stroke31 (Supplementary 
Note). The 96 N. americanus–specific SCP/TAPS identified here 
might serve as candidates for selective drug or vaccine targets32 
(Supplementary Table 5).
We identified a total of 336 N. americanus genes that are orthol-
ogous to previously predicted genes encoding immunogenic/ 
immunomodulatory proteins in Ascaris suum24, along with 
three homologs of genes encoding transforming growth factor-β  
(TGF-β), an important protein in modulation of inflammation and 
the evolution of nematode parasitism33 (Supplementary Table 5). 
Additional genes in N. americanus encoding proteins inferred to be 
involved in host-parasite immunomodulatory interactions include 
macrophage migration inhibitory factor (MIF), neutrophil inhibi-
tory factor (NIF), hookworm platelet inhibitor (HPI), galectins, 
C-type lectins (C-TL), peroxiredoxins (PRX) and glutathione 
S-transferases (GST), among others (Supplementary Note).
Prospects for new interventions
Historically, anthelmintic drugs have been discovered using in vivo 
and in vitro compound screens34. Recent comparative ‘omics’ studies 
(accompanied by experimental screening) in multiple nematode 
species10 have shown that genomic and transcriptomic data can be 
used to prioritize targets and raise the hit rate compared with con-
ventional approaches. Hence, the availability of the N. americanus 
genome is expected to enable comparative genomic and chemo-
genomic studies for the prediction and prioritization of therapeutic 
targets. As more than half (53%) of all current drug targets35 consist 
of rhodopsin-like G protein–coupled receptors (GPCRs), nuclear 
receptors (NRs), ligand-gated ion channels (LGICs), kinases and 
voltage-gated ion channels (VGICs), we investigated these protein 
groups in the N. americanus genome to identify potential therapeutic 
targets (Supplementary Table 9 and Supplementary Note).
GPCRs are attractive drug targets owing to their importance in 
signal transduction35. We identified 272 GPCR genes in N. americanus, 
whereas there are nearly 1,700 GPCR genes in C. elegans. Although 
GPCRs are challenging to characterize at the primary sequence level 
and the N. americanus genome is in a draft state, there may be a 
biological explanation for this difference in the number of GPCRs 
identified, including frequent amplifications of several subfamilies 
of GPCRs in C. elegans relative to the closely related Caenorhabditis 
briggsae36. Three of the five GRAFS families of GPCRs (glutamate, 
rhodopsin and frizzled, but not adhesion or secretin) were found in 
N. americanus. The putative GPCRs were enriched for iL3 overex-
pression (30 genes; P = 5.1 × 10−8), with only one gene being adult 
overexpressed (P = 4.1 × 10−7 for under-representation). N. america-
nus encodes members of both major ion-channel categories (LGICs 
and VGICs); 224 LGICs belonging to two of the three subfamilies of 
LGIC (Cys-loop family and glutamate-activated cation channels) were 
identified, compared with 159 LGIC-encoding genes in C. elegans37. 
Genes encoding nicotinic acetylcholine receptor subunits (nAChR) of 
Cys-loop family members were also found. Nematodes have a much 
larger number of nAChR-α subunits than examined vertebrates 
(17 nAChR-encoding genes in mammals and birds, compared with 
29 nAChR subunits in C. elegans38), and several anthelmintics such 
as levamisole39 and monepantel40 have been developed to exploit 
these differences. Ivermectin41 targets a subunit of glutamate-gated 
chloride channels that are present in N. americanus (eight genes; 
InterPro IPR015680); three of these genes clustered with six C. elegans 
glutamate-gated chloride channel genes (avr-14, avr-15 and glc-1 to 
glc-4; ref. 42). The lack of a clear ortholog of the ivermectin-sensitive 
genes within the N. americanus genome, and the underlying sequence 
diversity at a position correlated with direct activation by ivermectin, 
may explain the relative ivermectin insensitivity of N. americanus43 
(Supplementary Note and Supplementary Fig. 13) compared to 
other nematodes44.
VGICs include sodium, potassium and calcium channels and are 
anthelmintic targets (for example, emodepside inhibits SLO-1 in 
C. elegans45 and parasitic nematodes such as A. suum46). N. americanus 
encodes 48 VGICs (fewer than C. elegans), including members from 
the major families such as 6-transmembrane (6TM) potassium 
channels, voltage-gated calcium channels and voltage-gated chloride 
channels (Supplementary Note). As in other nematodes47, voltage-
gated sodium channels were not present in N. americanus.
Protein kinases are involved in numerous signal transduction 
pathways that regulate biological processes, and they have been a 
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major focus for drug discovery48,49. Of the 274 N. americanus genes 
encoding kinases, 15 and 12 were overexpressed in iL3 and adults, 
respectively. Gene expression, tissue expression, conservation among 
nematodes and dissimilarity to human orthologs were used for priori-
tization10 of candidate targets (Supplementary Table 10). To evalu-
ate current drugs and inhibitors that target homologous kinases, 
we also prioritized compounds from a publicly available database 
(Online Methods). The highest-scoring compound was a tyrosine 
kinase inhibitor approved for treating chronic myelogenous leuke-
mia9. A total of 233 other compounds had the second-highest score 
of 5 (Supplementary Table 11), indicating that these existing drugs 
might be repurposed for treating neglected tropical diseases, thus 
minimizing development time and cost50.
Chokepoints in metabolic pathways51 were analyzed and priori-
tized to identify further drug targets. N. americanus encodes at least 
3,976 protein-coding genes associated with 3,265 KEGG orthology 
terms (Supplementary Table 7), 938 (24%) of which are involved 
in metabolic pathways (Supplementary Fig. 14), representing 32 
potentially complete modules. A total of 34% of the metabolic path-
way genes were classified as chokepoints (Supplementary Table 12), 
of which 120 were conserved among nematodes and non-nematode 
species used in the comparative analysis. Chokepoint prioritization, 
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Figure 3 SCP/TAPS gene family expansion in N. americanus. (a) SCPs/TAPS are enriched in the adult stage of N. americanus. (b) Schematic 
representation of gene structure from SCP/TAPS family members. All SCP/TAPS proteins are grouped according to their number of CAP domains and 
regions outside the CAP domains: single CAP domain, double CAP domain, single CAP plus miscellaneous, and double CAP plus miscellaneous.  
(c) Neighbor-joining clustering of the all C. elegans and ungapped N. americanus SCP/TAPS genes on the basis of their full-length primary sequence 
similarity of the CAP domain. Data on domain representation, secretion type and stage of expression are included.
np
g
© 
20
14
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
Nature GeNetics  VOLUME 46 | NUMBER 3 | MARCH 2014 267
A rt i c l e s
along with requirements for a chokepoint to 
be an expression bottleneck in N. americanus 
and for lethality upon RNAi knockdown of 
the orthologous gene in C. elegans, priori-
tized eight enzymes encoded by ten distinct 
genes (Supplementary Tables 12–14 and 
Supplementary Note). Among the priori-
tized chokepoints is adenylosuccinate lyase 
(ASL; EC 4.3.2.2) (Supplementary Figs. 15–17), an enzyme involved 
in the purine metabolism pathway (KEGG pathway ko00230) and 
a chokepoint in the adenine ribonucleotide biosynthesis module 
(KEGG pathway M00049). To identify chokepoint inhibitors for 
repurposing, we assessed compounds from publicly available data-
bases (449 target-compound pairs) using the same method as for 
kinase inhibitors. The highest-ranked candidates include com-
pounds such as azathioprine (DrugBank DB00993), a prodrug that 
is converted into mercaptopurine (DrugBank DB01033) to inhibit 
purine metabolism and DNA synthesis (Supplementary Fig. 18, 
Supplementary Table 14 and Supplementary Note).
Postgenomic exploration using the N. americanus immunome
The N. americanus genome enables development of postgenomic 
tools to investigate the immunobiology of human hookworm dis-
ease and accelerate antigen discovery for the development of vac-
cines and diagnostics. We developed a protein microarray containing 
564 N. americanus recombinant proteins inferred from the genome 
(Supplementary Table 15 and Supplementary Note). The micro-
array was probed with sera from individuals aged 4–66 years who 
were residents in an N. americanus–endemic area of northeastern 
Minas Gerais state in Brazil. This pilot study based on 200 individu-
als from the youngest (<14 years of age) and the oldest (>45 years 
of age) age strata identified 22 antigens that were significant (P ≤ 0.05) 
targets of anti-hookworm immune responses (Fig. 4).
Older individuals showed stronger immunoglobin G (IgG) 
responses to a larger number of secreted antigens, but these anti-
bodies seem to have no role in killing the parasite or protecting 
against heavy infection. Hence, unlike other STHs of humans, pro-
tective immunity to N. americanus does not seem to develop in most 
individuals during adolescence. This is consistent with observa-
tions that, in Necator-endemic areas, older people often harbor 
the heaviest-intensity infections1,52,53. Younger individuals showed 
IgG responses against fewer antigens, usually with lower intensity. 
Thus, although antibodies are a key feature of the immune response 
to N. americanus and increase with host age, they do not protect 
individuals from infection over time.
There are probably multiple factors contributing to the absence of 
overall protective immunity to hookworm infection, in contrast to 
the age-acquired protective immunity observed with other STH 
infections. Detailed kinetic studies of the IgG subclasses and IgE 
responses to hookworm antigens represented on our protein micro-
array will be required to better understand the roles of these anti-
bodies in the acquisition of immunity against hookworm13. The 
protein microarray can be probed with sera from individuals with 
different genetic backgrounds and different histories of exposure 
to hookworm54, as well as from animals rendered immunologically 
resistant to hookworm infection by vaccination with irradiated iL3 
(ref. 55), thereby facilitating efforts to develop an efficacious vaccine 
against hookworm disease. Furthermore, secreted proteins that are 
recognized by most or all the infected individuals, and have weak 
or no homology to other nematode species, represent antigens that 
might form the basis of sensitive and specific serodiagnostic tests 
(Supplementary Note; for example, Supplementary Fig. 19).
DISCUSSION
N. americanus is responsible for causing more disease worldwide than 
any other STH. The characterization of the first genome of a human 
hookworm is expected to facilitate future fundamental explorations 
of the epidemiology and evolutionary biology of hookworms as well 
as efforts toward the development of therapeutics to combat hook-
worm disease. As N. americanus is the first hookworm whose genome 
has been sequenced, the data presented here provide a first insight 
into blood-feeding nematodes of major importance for human and 
animal health.
Our postgenomic exploration of inferred proteomic information 
highlights the utility of the draft genome sequence for understanding 
the immunobiology of human hookworm disease and accelerating 
Figure 4 Serum responses to N. americanus 
antigens vary with age and infection intensity. 
The heat map shows the immunoreactivity of 
22 antigens to the IgG antibodies from groups 
of uninfected individuals, infected children 
<14 years old and infected adults >45 years 
old (n = 8 in each group). Duplicate crude 
somatic extracts from iL3 and adult stages 
were included as control naive antigens. Every 
other row represents an individual recombinant 
in vitro translation product. The bar chart 
shows the mean immunoreactivity of the 
three groups for each antigen, measured by 
mean fluorescence intensity. ‘iL3’ and ‘Adult’ 
labels denote stage-specific expression of 
indicated antigens, measured by RNA-seq data. 
Significant differences in antibody responses 
between human adults and children were 
detected with Student’s t-test. *P < 0.05; 
**P < 0.01; ***P < 0.001; NS, no significant 
difference.
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the development of vaccines and diagnostics. It is also pertinent to 
note that hookworms are garnering interest for their therapeutic 
properties against a range of noninfectious inflammatory diseases 
of humans. The genome sequence therefore represents a veritable 
pharmacopoeia—indeed, recombinant hookworm molecules have 
already undergone clinical trials for stroke and deep-vein thrombosis15. 
Thus, the N. americanus genome sequence will have broad 
implications. It provides many opportunities to establish postgenomic 
methods in the quest to develop improved interventions against this 
ancient and neglected parasite, as well as inflammatory diseases that 
are reaching epidemic proportions in industrialized societies.
URLs. NCBI SRA, http://www.ncbi.nlm.nih.gov/sra; RepeatModeler, 
http://www.repeatmasker.org/RepeatModeler.html; RNAmmer, 
http://www.cbs.dtu.dk/services/RNAmmer/; Rfam database, http://
www.sanger.ac.uk/resources/databases/rfam.html; RepeatMasker, 
http://repeatmasker.org/; Fgenesh, www.softberry.com/; BER, http://
ber.sourceforge.net/; Seqclean, http://compbio.dfci.harvard.edu/tgi/
software/; Refcov, http://gmt.genome.wustl.edu/genome-shipit/gmt-
refcov/current/; PyMOL, www.pymol.org/; KEGG transcription 
factor database, http://www.genome.jp/kegg-bin/get_htext?ko03000.
keg; Jaspar database, http://jaspar.genereg.net/; Patser, http://stormo.
wustl.edu/resources.html; Kinomer, http://www.compbio.dundee.
ac.uk/kinomer; SignalP, www.cbs.dtu.dk/services/SignalP/.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. The whole-genome sequence of N. americanus has 
been deposited in DDBJ/EMBL/GenBank under the project acces-
sion ANCG00000000. The version described in this paper is the first 
version, ANCG01000000. All short-read data have been deposited in 
the Short Read Archive under the following accessions: SRR036799, 
SRR036800, SRR036802, SRR036804, SRR036811, SRR341459, 
SRR341460, SRR609850, SRR609895, SRR609951, SRR610281, 
SRR610282, SRR611341, SRR611350. RNA-seq profiles have been 
deposited in Nematode.net and a browsable genome is also available 
at Nematode.net and WormBase.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METhODS
Parasite material. The Anhui strain of N. americanus was maintained56 in 
Golden Syrian Hamster (3–4 weeks, male) from Harlan under the George 
Washington University Institutional Animal Care and Use Committee–
approved protocol 053-12.2, and in accordance with all Animal Welfare 
guidance. Adult worms were collected from intestines of hamsters infected 
subcutaneously with N. americanus iL3 for 8 weeks57. DNA was extracted with 
the QIAamp DNA Mini Kit according to manufacturer’s instruction (Qiagen). 
For transcriptome sequencing, two key developmental stages from a host-
parasite interaction perspective, the infective L3 (iL3; environmental) and 
adult (parasitic) worm stages, were collected.
Sequencing, assembly and annotation. Fragment, paired-end whole-genome 
shotgun libraries (3 kb and 8 kb insert sizes) were sequenced using Roche/454 
platform and assembled with Newbler58. A repeat library was generated 
(RepeatModeler) and repeats characterized (CENSOR59 v. 4.2.27 against 
RepBase release 17.03 (ref. 60)). Ribosomal RNA genes (RNAmmer61) and 
transfer RNAs (tRNAscan-SE62) were identified. Other noncoding RNAs were 
identified by a sequence homology search against the Rfam database63. Repeats 
and predicted RNAs were then masked using RepeatMasker. Protein-coding 
genes were predicted using a combination of ab initio programs64,65 and the 
annotation pipeline tool MAKER66. A consensus high-confidence gene set 
from the above prediction algorithms was generated (Supplementary Note). 
The size and number of exons and introns in N. americanus were determined 
by parsing exon sizes from gff-format annotations (considering only exon 
features tagged as “coding_exon”) and calculating intron sizes. These were 
then  compared to the C. elegans genes (WS230). Significant differences in exon 
and intron lengths and numbers were tested between species and orthologous 
and nonorthologous gene groups using two-tailed t-tests with unequal vari-
ance (Supplementary Note). Two separate approaches were used to identify 
putative operons in N. americanus (Supplementary Note). Gene product 
naming was determined by BER (JCVI) and functional categories of deduced 
proteins were assigned67–69. Orthologous groups were built from 13 species 
using OrthoMCL70, and genes not orthologous to the other 12 species were 
classified as N. americanus specific.
RNA sequencing. RNA was extracted18, DNase treated and used to generate 
both Roche/454 and Illumina cDNA libraries (Supplementary Note) that were 
sequenced using a Genome Sequencer Titanium FLX (Roche Diagnostics) and 
Illumina (Illumina, San Diego, CA), with slight modifications (Supplementary 
Note). The 454 cDNA reads were analyzed as previously described18. The 
Illumina RNA-seq data were processed71 and low-compositional complexity 
bases were masked72. RNA-seq reads were aligned73 to the predicted gene set 
and genes with a breadth of coverage ≥50% across the gene sequence (i.e., 
“expressed”) were used for further downstream analysis. Expression was 
quantified using expression values normalized to the depth of coverage per 
100 million mapped bases (DCPM). Expressed genes were subject to further 
differential expression analysis using EdgeR74 (false discovery rate <0.05) in 
order to identify stage-overexpressed genes (Supplementary Note).
Deduced proteome functional annotation and enrichment. Proteins were 
searched against KEGG75 using KAAS68 (cut-off 35 bits), and InterProScan69 
was used to get InterPro76 domain matches and Gene Ontology67 (GO) annota-
tions. Proteins with signal peptides77, nonclassical secretion78 and transmem-
brane topology77 were identified. The degradome was identified by comparison 
to the MEROPS79 protease unit database using WU-BLAST (identifying the 
best hit with E ≤ e−10). Enrichment of different protease groups among differ-
ent gene sets (based on similarity to C. elegans) was detected based on false 
discovery rate (FDR)-corrected binomial distribution probability tests80. GO 
enrichment significance comparing the iL3 and adult-overexpressed gene sets 
was calculated using FUNC81 at a 0.01 significance threshold after Family-
Wise Error Rate (FWER) population correction81. QuickGO82 was used to 
analyze the hierarchical structure of significant GO categories.
Proteomic analysis of somatic worm extract. Whole worms were ground 
under liquid nitrogen before solubilization in lysis buffer, total protein 
was precipitated, and established methods83 were used to reduce, alkylate 
and tryptic-digest two 1.5 mg samples of total somatic protein. Peptide frac-
tions were prepared before LC and mass spectral analysis (Supplementary 
Note). Only proteins confirmed with at least two peptides and a confidence of 
P ≤ 0.05 were considered identified. GO functional enrichment among the 
genes supported by proteomics was calculated81, using all of the genes without 
proteomics support as a background for comparison.
Transcription factors and binding sites. Transcription factors in 
N. americanus were identified by extracting KEGG Orthology (KO) numbers 
from the KEGG transcription factor database (derived from TRANSFAC 7.0 
(ref. 84)) and comparing to N. americanus KOs. Documented matrices of tran-
scription factor binding sites were downloaded from the JASPAR database85. 
The corresponding protein accession numbers were extracted and converted to 
KOs, and were compared to N. americanus transcription factor KOs to define 
a subset of N. americanus transcription factors with available binding site 
information. The binding site matrices of this subset of N. americanus tran-
scription factors were used to scan the sequences of up to 500 bp downstream 
and upstream of differentially expressed genes using Patser.
SCP/TAPS. Each protein was searched for the SCP/TAPS-representative pro-
tein domains86 IPR014044 (“CAP domain”) and PF00188 (“CAP”)86 using 
Interproscan69 and hmmpfam87. Phylogenetic relationship trees using full 
length primary sequences derived from ungapped genes were built using 
Bayesian inference88 and neighbor joining89 as previously described for other 
helminths32,86,90. Leaves of the tree were annotated with domain information, 
secretion mode and expression data, and then visualized using iTOL91.
Potential drug targets. GPCRs, LGICs and VGICs were identified with 
InterProScan69. Ion channels were identified using WU-BLASTP (E ≤ e−10) 
against the C. elegans proteome (WS230). For ivermectin target characteriza-
tion, sequence alignments were obtained by MUSCLE92 for the C. elegans 
and N. americanus orthologs within two orthologous groups (NAIF1.5_00184 
and NAIF1.5_06724). Homology models for the two N. americanus orthologs 
(NECAME_16744 and NECAME_16780) were built by MODELLER93 using 
the C. elegans crystal structure as template94. For each ortholog, five models 
were built and the one with the lowest total function score (energy) was chosen 
as the model shown. Sequence alignments are colored by Clustalx scheme in 
JalView95; protein structure models are rendered in PyMOL (Schrodinger, The 
PyMOL Molecular Graphics System, Version 1.3r1. 2010).
Kinome and chokepoints. N. americanus genes were screened against the col-
lection of kinase domain models in the Kinomer96, and custom score thresh-
olds were applied for each kinase group and then adjusted until an hmmpfam 
search87 came as close as possible to identifying known C. elegans kinases. 
Those same cutoffs were then applied to the N. americanus gene set to identify 
putative kinases as previously described97. Kinase prioritization was done by 
adapting the protocol previously described10 (Supplementary Note).
Chokepoints of KEGG metabolic pathways were defined as a reaction that 
either consumes a unique substrate or produces a unique product. The reac-
tion database from KEGG v58 (ref. 98) was used and the chokepoints were 
identified and prioritized as previously described99 (Supplementary Note). 
Metabolic module abundances were calculated (and normalized in DCPM) 
based on KAAS annotations68, and module bottlenecks were defined as reac-
tion steps in the cascade that both are essential for the module completion 
and have low enzyme abundance that primarily constrains the overall module 
abundance. Homology models were aligned with their reference sequence 
using T-COFFEE100, constructed with MODELLER101 using default param-
eters and PDB structures with the highest sequence similarity, and dock-
ing was performed using AutoDock4.2 (ref. 102) using default parameters. 
Chemogenomic screening for compound prioritization was performed as 
previously described99 (Supplementary Note).
Protein microarray. In 2005, 1494 individuals between the ages 4 and 66 years 
(inclusive) were enrolled (with informed consent) into a cross-sectional study 
in an N. americanus-endemic area of Northeastern Minas Gerais state in Brazil, 
using protocols approved by the George Washington University Institutional 
Review Board (117040 and 060605), the Ethics Committee of Instituto René 
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Rachou and the National Ethics Committee of Brazil (CONEP; protocol num-
bers 04/2008 and 12/2006). Venous blood (15 mL) was collected from indi-
viduals determined to be positive for N. americanus (Supplementary Note).
A total of 1,275 N. americanus open reading frames (ORFs) contained a 
classical signal peptide for secretion and had RNA-seq evidence for tran-
scription in iL3 and/or adult worms. Of those, 623 corresponding cDNAs 
were successfully amplified, cloned, expressed and the protein extracts 
were contact-printed without purification onto nitrocellulose glass FAST 
slides (Supplementary Note). The printed in vitro–expressed proteins were 
quality-checked using antibodies against incorporated N-terminal 
polyhistidine (His) and C-terminal hemagglutinin (HA) tags.
Protein arrays were blocked in blocking solution (Whatman) and probed 
with human sera overnight. Arrays were washed, and isotype- and subclass-
 specific responses were detected using biotinylated mouse monoclonal anti-
bodies against human IgG1 (Sigma, B6775, lot 031M4751, clone 8c/6-39), 
IgG3 (Sigma, B3523, lot 080M4811, clone HP-6050) and IgG4 (Sigma, B3648, 
lot 091M4783, clone HP-6025) and biotin-conjugated mouse monoclonal 
anti-human IgE Fc (Human Reagent Laboratory, Baltimore, MD, HP6061B). 
Microarrays were scanned using a GenePix microarray scanner (Molecular 
Devices). The data were analyzed using the “group average” method103, whereby 
the mean fluorescence was considered for analysis (Supplementary Note).
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